Refractory celiac disease type 2: how to diagnose and treat?
Rev. Assoc. Med. Bras. (1992)
;
67(2): 168-172, Feb. 2021. tab, graf
Article
in English
| LILACS
| ID: biblio-1287807
ABSTRACT
SUMMARY Refractory celiac disease is an uncommon condition which might be associated to poor prognosis. It is often treated with immunosuppressive medications, with poor results. It is divided in type 1 and type 2, the latter carrying a high risk for lymphoma and mortality. A case of a 41 year old female patient with refractory celiac disease type 2 is reported. She was treated with oral budesonide for six months, achieving histological remission.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Celiac Disease
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992)
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de Ciências da Saúde de Porto Alegre/BR
/
Universidade de Caxias do Sul/BR
Similar
MEDLINE
...
LILACS
LIS